# US 2021/0332129 A1 · Human antibody-producing cell

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0332129 A1
- Document ID: US20210332129A1
- Status: Published application
- Kind: A1
- Application number: 17/315,030
- Filed: 2021-05-07
- Published: 2021-10-28
- Earliest claimed: 2014-05-02
- Assignees: Chiome Bioscience Inc.
- Applicants: Chiome Bioscience Inc.
- Inventors: Shuichi Hashimoto; Tomoaki Uchiki; Shigehisa Kawata; Kenjiro Asagoshi; Takashi Yabuki; Hitomi Sano; Shunsuke Miyai; Naoki Takahashi; Aki Takesue; Atsushi Sawada
- Web page: https://patentgrep.com/patent/US20210332129A1

## CPC

- C07K 16/00: Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K 16/28: against receptors, cell surface antigens or cell surface determinants
- C07K 16/18: against material from animals or humans
- C07K 16/22: against growth factors {; against growth regulators}
- C07K 16/244: {Interleukins [IL]}
- C12N 5/00: Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor; (plant reproduction by tissue culture techniques A01H4/00)
- C12N 5/0635: {B lymphocytes}
- C12N 5/10: Cells modified by introduction of foreign genetic material
- C12N 15/00: Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (mutants or genetically engineered microorganisms, per se C12N1/00, C12N5/00, C12N7/00; new plants per se A01H; plant reproduction by tissue culture techniques A01H4/00; new animals per se A01K67/00; use of medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases, gene therapy A61K48/00)
- C12N 15/09: Recombinant DNA-technology
- C40B 40/02: Libraries contained in or displayed by microorganisms, e.g. bacteria or animal cells; Libraries contained in or displayed by vectors, e.g. plasmids; Libraries containing only microorganisms or vectors
- C07K 2317/14: Specific host cells or culture conditions, e.g. components, pH or temperature
- C07K 2317/21: from primates, e.g. man
- C07K 2317/51: Complete heavy chain or Fd fragment, i.e. VH + CH1
- C07K 2317/515: Complete light chain, i.e. VL + CL
- C07K 2317/565: Complementarity determining region [CDR]
- C12N 2510/02: Cells for production
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C40B: COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES (in silico combinatorial libraries of nucleic acids, proteins or peptides G16B35/00; in silico combinatorial chemistry G16C20/60)

## Abstract

A chicken B cell that expresses a variety of human antibodies. A chicken B cell, in which, in an antibody light chain gene locus thereof, all or a part of a DNA sequence derived from a human antibody light chain variable region and a human antibody light chain constant region are inserted, or the antibody light chain gene locus is replaced with all or a part of a DNA sequence derived from human antibody light chain variable and constant regions, and in an antibody heavy chain gene locus thereof, all or a part of a DNA sequence derived from human antibody heavy chain variable and constant regions are inserted, or the antibody heavy chain gene locus is replaced with all or a part of a DNA sequence derived from human antibody heavy chain variable and constant regions, and in an antibody light chain pseudogene locus thereof, two or more DNA sequences derived from human antibody light chain variable regions are inserted, or the antibody light chain pseudogene locus is replaced with two or more DNA sequences derived from human antibody light chain variable regions, and/or in an antibody heavy chain pseudogene locus thereof, two or more DNA sequences derived from human antibody heavy chain variable regions are inserted, or the antibody heavy chain pseudogene locus is replaced with two or more DNA sequences derived from human antibody heavy chain variable regions.

## Claims

### Claim 1

(canceled)

### Claim 2

A chicken B cell, in which the chicken antibody light chain gene locus is replaced by all or a part of a DNA sequence derived from a human antibody light chain variable region and by all or a part of a DNA sequence derived from a human antibody light chain constant region,
which in the chicken antibody heavy chain gene locus all or a part of a DNA sequence derived from a human antibody heavy chain variable region and of a human antibody heavy chain constant region are inserted,
and in which the chicken antibody light chain pseudogene locus is replaced by 15 or more DNA sequences derived from human antibody light chain variable regions,
and in which the chicken antibody heavy chain pseudogene locus is inserted by 15 or more DNA sequences derived from human antibody heavy chain variable regions,
wherein the chicken B cell has the ability to express a human antibody on the cell surface and also to secrete the human antibody into the culture solution, and wherein a complementarity-determining region 3 (CDR3) encoded by the human antibody light chain and heavy chain variable regions comprises more than 5 different amino acids.

### Claim 3 (depends on 2)

The chicken B cell according to claim 2, in which the chicken antibody light chain pseudogene locus is replaced by DNA sequence comprising SEQ ID NO:74, SEQ ID NO:75, SEQ ID NO:76, SEQ ID NO:77, SEQ ID NO:78, SEQ ID NO:79, SEQ ID NO:80, SEQ ID NO:81, SEQ ID NO:82, SEQ ID NO:83, SEQ ID NO:84, SEQ ID NO:85, SEQ ID NO:86, SEQ ID NO:87, and SEQ ID NO:88,
and in which the chicken antibody heavy chain pseudogene locus is inserted by DNA sequence comprising SEQ ID NO:94, SEQ ID NO:95, SEQ ID NO:96, SEQ ID NO:97, SEQ ID NO:98, SEQ ID NO:99, SEQ ID NO:100, SEQ ID NO:101, SEQ ID NO:102, SEQ ID NO:103, SEQ ID NO:104, SEQ ID NO:105, SEQ ID NO:106, SEQ ID NO:107, and SEQ ID NO:108.

### Claim 4 (depends on 2)

The chicken B cell according to claim 2, in which the chicken antibody light chain pseudogene locus is replaced by DNA sequence comprising SEQ ID NO:74, SEQ ID NO:75, SEQ ID NO:76, SEQ ID NO:77, SEQ ID NO:78, SEQ ID NO:79, SEQ ID NO:80, SEQ ID NO:81, SEQ ID NO:82, SEQ ID NO:83, SEQ ID NO:84, SEQ ID NO:85, SEQ ID NO:86, SEQ ID NO:87, and SEQ ID NO:88,
and in which the chicken antibody heavy chain pseudogene locus is inserted by DNA sequence comprising SEQ ID NO:94, SEQ ID NO:95, SEQ ID NO:96, SEQ ID NO:97, SEQ ID NO:98, SEQ ID NO:99, SEQ ID NO:100, SEQ ID NO:101, SEQ ID NO:102, SEQ ID NO:103, SEQ ID NO:104, SEQ ID NO:105, SEQ ID NO:106, SEQ ID NO:107, SEQ ID NO:108, SEQ ID NO:110, SEQ ID NO:111, SEQ ID NO:112, SEQ ID NO:113, SEQ ID NO:114, SEQ ID NO:115, SEQ ID NO:116, SEQ ID NO:117, SEQ ID NO:118, SEQ ID NO:119, SEQ ID NO:120, SEQ ID NO:121, SEQ ID NO:122, SEQ ID NO:123, and SEQ ID NO:124.

### Claim 5 (depends on 2)

The chicken B cell according to claim 2, and in which the chicken antibody light chain pseudogene locus is replaced by DNA sequence comprising SEQ ID NO:74, SEQ ID NO:75, SEQ ID NO:76, SEQ ID NO:77, SEQ ID NO:78, SEQ ID NO:79, SEQ ID NO:80, SEQ ID NO:81, SEQ ID NO:82, SEQ ID NO:83, SEQ ID NO:84, SEQ ID NO:85, SEQ ID NO:86, SEQ ID NO:87, SEQ ID NO:88, SEQ ID NO:127, SEQ ID NO:128, SEQ ID NO:129, SEQ ID NO:130, SEQ ID NO:131, SEQ ID NO:132, SEQ ID NO:133, SEQ ID NO:134, SEQ ID NO:135, SEQ ID NO:136, SEQ ID NO:137, SEQ ID NO:138, SEQ ID NO:139, SEQ ID NO:140, and SEQ ID NO:141,
and in which the chicken antibody heavy chain pseudogene locus is inserted by DNA sequence comprising SEQ ID NO:94, SEQ ID NO:95, SEQ ID NO:96, SEQ ID NO:97, SEQ ID NO:98, SEQ ID NO:99, SEQ ID NO:100, SEQ ID NO:101, SEQ ID NO:102, SEQ ID NO:103, SEQ ID NO:104, SEQ ID NO:105, SEQ ID NO:106, SEQ ID NO:107, SEQ ID NO:108, SEQ ID NO:110, SEQ ID NO:111, SEQ ID NO:112, SEQ ID NO:113, SEQ ID NO:114, SEQ ID NO:115, SEQ ID NO:116, SEQ ID NO:117, SEQ ID NO:118, SEQ ID NO:119, SEQ ID NO:120, SEQ ID NO:121, SEQ ID NO:122, SEQ ID NO:123, and SEQ ID NO:124.

### Claim 6 (depends on 2)

The chicken B cell according to claim 2, in which the chicken antibody light chain pseudogene locus is replaced by DNA sequence comprising SEQ ID NO:74, SEQ ID NO:75, SEQ ID NO:76, SEQ ID NO:77, SEQ ID NO:78, SEQ ID NO:79, SEQ ID NO:80, SEQ ID NO:81, SEQ ID NO:82, SEQ ID NO:83, SEQ ID NO:84, SEQ ID NO:85, SEQ ID NO:86, SEQ ID NO:87, SEQ ID NO:88, SEQ ID NO:127, SEQ ID NO:128, SEQ ID NO:129, SEQ ID NO:130, SEQ ID NO:131, SEQ ID NO:132, SEQ ID NO:133, SEQ ID NO:134, SEQ ID NO:135, SEQ ID NO:136, SEQ ID NO:137, SEQ ID NO:138, SEQ ID NO:139, SEQ ID NO:140, and SEQ ID NO:141,
and in which the chicken antibody heavy chain pseudogene locus is inserted by DNA sequence comprising SEQ ID NO:94, SEQ ID NO:95, SEQ ID NO:96, SEQ ID NO:97, SEQ ID NO:98, SEQ ID NO:99, SEQ ID NO:100, SEQ ID NO:101, SEQ ID NO:102, SEQ ID NO:103, SEQ ID NO:104, SEQ ID NO:105, SEQ ID NO:106, SEQ ID NO:107, SEQ ID NO:108, SEQ ID NO:110, SEQ ID NO:111, SEQ ID NO:112, SEQ ID NO:113, SEQ ID NO:114, SEQ ID NO:115, SEQ ID NO:116, SEQ ID NO:117, SEQ ID NO:118, SEQ ID NO:119, SEQ ID NO:120, SEQ ID NO:121, SEQ ID NO:122, SEQ ID NO:123, SEQ ID NO:124, SEQ ID NO:147, SEQ ID NO:148, SEQ ID NO:149, SEQ ID NO:150, SEQ ID NO:151, SEQ ID NO:152, SEQ ID NO:153, SEQ ID NO:154, SEQ ID NO:155, SEQ ID NO:156, SEQ ID NO:157, SEQ ID NO:158, SEQ ID NO:159, SEQ ID NO:160, and SEQ ID NO:161.

### Claim 7 (depends on 2)

The chicken B cell according to claim 2, wherein the DNA sequence derived from the human antibody light chain variable region inserted into the antibody light chain gene locus is at a position upstream from the DNA sequence derived from the human antibody light chain constant region, and the DNA sequence derived from the human antibody heavy chain variable region inserted into the antibody heavy chain gene locus is at a position upstream from the DNA sequence derived from the human antibody heavy chain constant region.

### Claim 8 (depends on 2)

The chicken B cell according to claim 2, wherein the human antibody heavy chain is a γ chain.

### Claim 9 (depends on 2)

The chicken B cell according to claim 2, wherein the human antibody light chain is a λ chain or a κ chain.

### Claim 10 (depends on 2)

The chicken B cell according to claim 2, which is a DT40 cell.

### Claim 11 (depends on 2)

The chicken B cell according to claim 2, which has been subjected to a treatment of relaxing chromatin.

### Claim 12 (depends on 11)

The chicken B cell according to claim 11, wherein the treatment of relaxing chromatin is reduction or deletion of the function of histone deacetylase in the chicken B cell.

### Claim 13 (depends on 12)

The chicken B cell according to claim 12, wherein the method for reducing or deleting the function of histone deacetylase is reduction or deletion of the expression of a histone deacetylase gene in the chicken B cell.

### Claim 14 (depends on 13)

The chicken B cell according to claim 13, wherein the histone deacetylase is HDAC2.

### Claim 15 (depends on 12)

The chicken B cell according to claim 12, wherein the method for reducing or deleting the function of histone deacetylase is a treatment with an HDAC inhibitor.

### Claim 16 (depends on 2)

An antibody-producing cell library consisting of the chicken B cell according to claim 2.

### Claim 17 (depends on 2)

A method for producing a human antibody or a humanized antibody from the chicken B cell according to claim 2, comprising culturing said chicken B cell under culturing conditions suitable for the cell to produce a human antibody or a humanized antibody and obtaining said antibody.

### Claim 18 (depends on 16)

Antibodies reacting with various antigens, wherein said antibodies have been produced by the cell library according to claim 16.

### Claim 19 (depends on 2)

A kit for producing the chicken B cells according to claim 2.

### Claim 20 (depends on 17)

The method of claim 17, wherein the antibody is comprised in a pharmaceutical product.
